Persevere Therapeutics: Funding, Investors & Team (Sep 2026)
Persevere Therapeutics is a clinical-stage pharmaceutical company that advances the development of GP-2250 novel oncology therapeutics focused on improving the effectiveness of cancer treatments.
Persevere Therapeutics has raised $1.6M across 1 funding round on record, the most recent a Seed of $1.6M announced in Mar 2026.
That round is below the $4.8M median round size for Health Care companies tracked on FundedIQ over the last two years.
Persevere Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Persevere Therapeutics Funding Rounds
Persevere Therapeutics Founders and Leadership Team
Contact details for the Persevere Therapeutics team: 1 has a LinkedIn profile.
Start 14-day free trial →Persevere Therapeutics Funding Compared to Other Health Care Startups
Persevere Therapeutics' latest round of $1.6M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Persevere Therapeutics in Health Care and Berwyn
Companies Similar to Persevere Therapeutics
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Thyme Care is an oncology solution that integrates patients and providers, working with health plans to…
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Persevere Therapeutics Funding FAQs
What does Persevere Therapeutics do?
Persevere Therapeutics is a clinical-stage pharmaceutical company that advances the development of GP-2250 novel oncology therapeutics focused on improving the effectiveness of cancer treatments.
How much funding has Persevere Therapeutics raised?
Persevere Therapeutics has raised $1.6M across 1 round on record. The most recent is a Seed of $1.6M announced in Mar 2026.
When did Persevere Therapeutics last raise funding?
Persevere Therapeutics' most recent funding round on record is a Seed of $1.6M, announced in Mar 2026.
Who founded Persevere Therapeutics?
FundedIQ lists Greg Bosch (Founder) at Persevere Therapeutics.
Where is Persevere Therapeutics headquartered?
Persevere Therapeutics is based in Berwyn, Pennsylvania, United States.
How many employees does Persevere Therapeutics have?
Persevere Therapeutics is in the 11-50 employee band.
How does Persevere Therapeutics' funding compare to other Health Care startups?
Persevere Therapeutics' latest round of $1.6M is below the $4.8M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Persevere Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Persevere Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.